RecruitingPhase 3NCT02000089
The Cancer of the Pancreas Screening-5 CAPS5)Study
Studying Peutz-Jeghers syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Michael Goggins, MDJohns Hopkins University
- Intervention
- Secretin(drug)
- Enrollment
- 9000 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2029
Study locations (9)
- Yale University, New Haven, Connecticut, United States
- Johns Hopkins Hospital, Baltimore, Maryland, United States
- Dana Farber Cancer Center, Harvard University, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- NYU Langone Medical Center, New York, New York, United States
- Columbia University Medical Center, New York, New York, United States
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Collaborators
National Cancer Institute (NCI) · National Institutes of Health (NIH) · American Association for Cancer Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02000089 on ClinicalTrials.govOther trials for Peutz-Jeghers syndrome
Additional recruiting or active studies for the same condition.